Reversible posterior leukoencephalopathy syndrome in hepatitis C virus-positive long-term hemodialysis patients
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 • 3,550 citations
A Reversible Posterior Leukoencephalopathy Syndrome
1996 • 3,244 citations
Impact of hepatitis B and C virus on kidney transplantation outcome
1999 • 542 citations
THE PATHOGENESIS OF HYPERTENSIVE ENCEPHALOPATHY AND ITS RELATION TO THE MALIGNANT PHASE OF HYPERTENSION EXPERIMENTAL EVIDENCE FROM THE HYPERTENSIVE RAT
1954 • 415 citations
Hepatitis C virus infection in dialysis and renal transplantation
1997 • 387 citations
Clinical Toxicity of the Interferons
1994 • 268 citations
HARMFUL LONG-TERM IMPACT OF HEPATITIS C VIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS
1998 • 258 citations
Posterior leukoencephalopathy syndrome may not be reversible
1999 • 200 citations
Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function
1998 • 172 citations
Interferon treatment for chronic hepatitis C virus infection in uremic patients
1994 • 113 citations
Seizures in Dialysis Patients Treated with Recombinant Erythropoietin. Review of the Literature and Guidelines for Prevention
1994 • 40 citations
Epidemiology of HCV infection in the general population and in blood transfusion
1996 • 36 citations
Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.
1986 • 23 citations
Uncommon side‐effects of interferon
1997 • 18 citations
Cited By (0)
No citing papers found in database